Publications by authors named "Jean-Marc Extra"

Claim this Profile
L
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
Xavier Pivot, Jean-Philippe Spano, Marc Espie, Christelle Jouannaud, Valerie Pottier, Jean Marc Extra

Clin Breast Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
François Bertucci, Anthony Gonçalves, Arnaud Guille, José Adelaïde, Séverine Garnier, Jean-Marc Extra

Genome Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer.
Renaud Sabatier, Johan Martin, Cécile Vicier, Mathilde Guérin, Audrey Monneur, Jean-Marc Extra

J Clin Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cells and Bevacizumab Pharmacokinetics during Neoadjuvant Treatment Combining Chemotherapy and Bevacizumab for Early Breast Cancer: Ancillary Analysis of the AVASTEM Trial.
Renaud Sabatier, Jean-Yves Pierga, Hervé Curé, Rakan Abulnaja, Eric Lambaudie, Jean-Marc Extra

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Response to Cetuximab in a Patient With -Amplified Heavily Pretreated Metastatic Triple-Negative Breast Cancer.
Renaud Sabatier, Marc Lopez, Arnaud Guille, Emilien Billon, Nadine Carbuccia, Jean-Marc Extra

JCO Precis Oncol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer.
Renaud Sabatier, Emmanuelle Charafe-Jauffret, Jean-Yves Pierga, Hervé Curé, Eric Lambaudie, Jean-Marc Extra

J Clin Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer.
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra

Cancer Res Treat· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of eribulin for "real-world" older patients with metastatic breast cancer.
Alexandre de Nonneville, Renaud Sabatier, Anthony Gonçalves, Jean-Marc Extra, Carole Tarpin

J Geriatr Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIKHER2: A phase IB study evaluating buparlisib in combination with lapatinib in trastuzumab-resistant HER2-positive advanced breast cancer.
Mathilde Guerin, Keyvan Rezai, Nicolas Isambert, Mario Campone, Aurélie Autret, Jean-Marc Extra

Eur J Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory locally advanced breast cancers.
Audrey Monneur, Anthony Goncalves, Marine Gilabert, Pascal Finetti, Carole Tarpin, Jean-Marc Extra

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].
Laurys Boudin, Christian Chabannon, Patrick Sfumato, Renaud Sabatier, François Bertucci, Jean-Marc Extra

Bull Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].
Laurys Boudin, Christian Chabannon, Patrick Sfumato, Renaud Sabatier, François Bertucci, Jean-Marc Extra

Eur J Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.
Anthony Gonçalves, François Bertucci, Arnaud Guille, Severine Garnier, José Adelaide, Jean-Marc Extra

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of hormone receptor- and HER2-defined subtypes in inflammatory breast cancer treated with high-dose chemotherapy: a retrospective study.
Laurys Boudin, Anthony Gonçalves, Patrick Sfumato, Renaud Sabatier, François Bertucci, Jean-Marc Extra

J Cancer· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.
Renaud Sabatier, Laura Sabiani, Christophe Zemmour, Sébastien Taix, Elisabeth Chereau, Jean-Marc Extra

Breast· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.
Laurys Boudin, Christian Chabannon, Patrick Sfumato, Renaud Sabatier, François Bertucci, Jean-Marc Extra

Eur J Cancer· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
METRO1: A Phase I Study of Metronomic Chemotherapy in Adults with Advanced Refractory Solid Tumors.
Simon Launay, Renaud Sabatier, Serge Brunelle, Benjamin Esterni, Carole Tarpin, Jean-Marc Extra

Anticancer Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of BRCA1 germ-line mutation status in patients with breast cancer using histoprognosis grade, MS110, Lys27H3, vimentin, and KI67.
Mohamed Hassanein, Laetitia Huiart, Violaine Bourdon, Laetitia Rabayrol, Jeanine Geneix, Jean Marc Extra

Pathobiology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].
Anthony Gonçalves, Renaud Sabatier, Emmanuelle Charafe-Jauffret, Marine Gilabert, Magali Provansal, Jean-Marc Extra

Bull Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are there candidates for high-dose chemotherapy in ovarian carcinoma?
Renaud Sabatier, Anthony Gonçalves, François Bertucci, Maria-Antonietta Capiello, Frédérique Rousseau, Jean-Marc Extra

J Exp Clin Cancer Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Targeted chemotherapy for breast cancer: patients perception of the use of tumor gene profiling approaches to better adapt treatments].
Isabelle Pellegrini, Myrto Rapti, Jean-Marc Extra, Anouk Petri-Cal, Themis Apostolidis

Med Sci (Paris)· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritumoural vascular invasion: a major determinant of triple-negative breast cancer outcome.
Renaud Sabatier, Jocelyne Jacquemier, François Bertucci, Benjamin Esterni, Pascal Finetti, Jean-Marc Extra

Eur J Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life at 2 years follow-up after sentinel lymph node biopsy, immediate or delayed axillary dissection for breast cancer.
Maryam Al Nakib, Max Buttarelli, Laetitia Huiart, Marc Martino, Carole Tarpin, Jean Marc Extra

Breast J· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.
Marine Gilabert, François Bertucci, Benjamin Esterni, Anne Madroszyk, Carole Tarpin, Jean-Marc Extra

Anticancer Res· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Jean-Marc Extra, Eric C Antoine, Anne Vincent-Salomon, Thierry Delozier, Pierre Kerbrat

Oncologist· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis